Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 81-89
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.81
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.81
Table 1 Demographic data of patients included in analysis
Pathway | No. of patients | BMI Median (IQR) | Age Median (IQR) | Sex | |
Standard care pathway | 16 | 26.8 (23.0-31.9) | 70.5 (60.0-76.0) | Female | 14 |
Male | 2 | ||||
IRAT | 15 | 27.7 (22.8-35.8) | 66.0 (59.0-77.0) | Female | 12 |
Male | 3 | ||||
P value | 0.77 | 0.6 | 0.57 |
Table 2 Detailing obstetric history and concurrent urinary incontinence in patients included in analysis
Pathway | Vaginal delivery | Difficult labour | Perineal tear | Forceps delivery | Concurrent urinary incontinence | symptoms of global pelvic floor weakness |
Standard care pathway | 14/14 | 10 | 9 | 6 | 13 | 9 |
IRAT | 12/14 | 9 | 8 | 4 | 9 | 6 |
P value | 0.21 | 0.32 | 0.26 | 0.36 | 0.18 | 0.17 |
Table 3 detailing anorectal laboratory test results in patients included in the analysis
Anorectal physiology variables | IRAT pathway Median (IQR) | Standard care pathway Median (IQR) | P value |
MMRP | 46.0 (36.0-80.0) | 55 (38.5-72) | 0.96 |
MMSP | 74.0 (57.0-89.0) | 50.0 (37.0-72.0) | 0.88 |
Resting victor volume | 33308.0 (16559.2-54994.0) | 51224.0 (29444.0-77663.0) | 0.17 |
Squeeze victor volume | 61168.0 (44393.0-165403.0) | 81303 (51751.0-118808.5) | 0.79 |
Squeeze asymmetry | 29.7 (11.7-27.1) | 14.4 (8.4-16.9) | 0.07 |
Resting asymmetry | 20.9 (13.5-31.0) | 17.9 (11.2-27.1) | 0.41 |
USS-IAS | 2 abnormal | 2 abnormal | 1.00 |
USS-EAS | 2 abnormal | 1 abnormal | 0.59 |
Resting vectrogram | 4 abnormal | 5 abnormal | 0.94 |
Squeeze vectrogram | 3 abnormal | 5 abnormal | 0.43 |
TRV | 85 (50-100) | 80 (50-95) | 0.85 |
MRV | 140 (100-195) | 140 (100-195) | 0.94 |
AME (high) | 6.5 ( 5.2-10.6) | 7.1 (5.5-11.3) | 0.93 |
AME (mid) | 5.3 (3.6-7.5) | 5.9 (4.6-7.7) | 0.89 |
AME (low) | 4.7 (2.8-6.6) | 5.1 (3.0-6.5) | 0.85 |
Table 4 Comparison between baseline rockwood faecal incontinence quality of life scales of both study groups
Baseline | FIQoLS 1 Median (IQR) | FIQoLS 2 Median (IQR) | FIQoLS 3 Median (IQR) | FIQoLS 4 Median (IQR) |
IRAT pathway | 3.6 (2.0.2-4) | 2.7 (1.4-3.4) | 3.7 (2.3-4.1) | 2.7 (1.3-3.8) |
Standard care pathway | 3.5 (2.3-3.7) | 2.4 (1.6-3.0) | 3.1 (2.0-3.7) | 2.0 (1.3-2.7) |
P value | 0.44 | 0.94 | 0.11 | 0.22 |
Table 5 Comparison between baseline St. marks incontinence score and cleveland clinic incontinence score of both study groups
Baseline | CCIS Median (IQR) | SMIS Median (IQR) |
IRAT pathway | 8.0 (33.5-11.5) | 13.0 (5.5-13.0) |
Standard care pathway | 9.5 (5.0-15.0) | 12.0 (7.0-16.0) |
P value | 0.11 | 0.18 |
Table 6 Comparison between Rockwood Faecal Incontinence Quality of Life Scales of both study groups after completion of management
After completion of management | FIQoLS 1 Median (IQR) | FIQoLS 2 Median (IQR) | FIQoLS 3 Median (IQR) | FIQoLS 4 Median (IQR) |
IRAT pathway | 3.9 (2.2- 4.0) | 2.9 (1.8 3.8) | 3.9 (2.3-4.1) | 3.0 (1.8-3.8) |
Standard care pathway | 3.6 (2.4-4.0) | 3.8 (1.7-4.0) | 3.5 (2.1-3.9) | 2.3 (1.6-3.7) |
P value | 0.51 | 0.92 | 0.18 | 0.87 |
Table 7 Comparison between St. marks incontinence score and cleveland clinic incontinence score of both study groups after completion of management
After completion of management | CCIS Median (IQR) | SMIS Median (IQR) |
IRAT pathway | 6.0 (1.5 -11.5) | 7.0 (30-15.5) |
Standard care pathway | 7.5 (3.0-12.0) | 9.5 (4.0-11.0) |
P value | 0.37 | 0.85 |
Table 8 Comparison of patient satisfaction score between the integrated rapid assessment and treatment and the standard care pathways
Please rate your degree of satisfaction with each of the following aspect | Standard care pathway median (IQR) | IRAT pathway median (IQR) | P value |
The waiting time from seeing your GP until been seen at York hospital was acceptable | 4 (3-4) | 4 (4-5) | 0.07 |
The waiting time from being seen at York Hospital until completing your treatment was acceptable | 4 (3-4) | 4 (4-5) | 0.03 |
The questions you were asked to complete were relevant to your problem? | 4 (4-4) | 4 (4-5) | 0.24 |
The questions you were asked to complete were clear and easy to answer? | 4 (4-4) | 4 (4-5) | 0.28 |
The questions you were asked to complete covered all aspect of your problem? | 4 (3-4) | 4 (4-5) | 0.01 |
You were supported and given clear advices/instructions throughout management | 4 (4-4) | 4 (4-5) | 0.08 |
You were given enough time to explain your problem/concerns | 4 (4-4) | 4 (4-5) | 0.08 |
Your privacy and dignity were respected throughout management | 4 (4-5) | 4 (4-5) | 0.43 |
The over all quality of care you received was high | 4.5 (4-5) | 4 (4-5) | 0.85 |
- Citation: Hussain ZI, Lim M, Stojkovic S. Role of clinical pathway in improving the quality of care for patients with faecal incontinence: A randomised trial. World J Gastrointest Pharmacol Ther 2017; 8(1): 81-89
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/81.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.81